This article examines the evidence for the cardiovascular safety of testosterone replacement therapy in older men with non-specific symptoms and unexplained low testosterone levels.

Written by Prof Robert I McLachlan, FRACP, PhD, AM

Professor Robert McLachlan is a NHMRC Principal Research Fellow at the Hudson Institute of Medical Research is the Director of Andrology Australia and Deputy Director of Endocrinology at Monash Medical Centre. Rob specialises in the area of male reproductive medicine and has made significant contributions to research in endocrinology, infertility and andrology.